Gen-Probe Incorporated, a global molecular diagnostics company headquartered in San Diego, California, has chosen Manchester to substantially expand its European operations and help grow its international business.
Gen-Probe is expanding its footprint in Wythenshawe, Manchester from 11,000 sq ft to 60,000 sq ft. The property, Innovation House, will be leased from property investment and development company Bluemantle, and the refurbishment will be undertaken by Boulting Environmental Services (BES). The move has received public sector support and assistance from Manchester City Council and MIDAS (Manchester Investment Development Agency Service).
The expanded site will focus on the manufacture of Gen-Probe’s women’s health products and genetic disease testing products for the global market. In addition, a suite of bespoke contract service laboratories will provide consolidated molecular genetic services to the pharmaceutical and academic arenas. The site will also become the Company’s European finance and administrative headquarters supporting Gen-Probe’s locations throughout Europe.
“We are excited by this decision as we believe that it will support the Company’s growth in Europe over the next few years. It also creates an opportunity for increased efficiencies in our operations and allows us to establish an R&D ‘Centre of Excellence’ in Manchester” said Carl Hull, Gen-Probe’s President and Chief Executive Officer. “This location is excellent for us in terms of its proximity to the international airport, and also provides a talented pool of scientists from local universities and research institutes.”
Tim Newns, Deputy Chief Executive of MIDAS, adds: “MIDAS is delighted that we were able to work with Gen-Probe, Bluemantle and Manchester City Council to secure Gen-Probe’s new European HQ facility, which is a real shot in the arm for Wythenshawe and Manchester as not only will it result in significant job creation but it further reinforces the attractiveness of the region for such investments. It also meets the City’s ambitions to continue to evolve as a world centre for science and technology.”
Mark Caldwell, Chief Executive of Bluemantle, says: “We have worked very closely with Gen-Probe over the last 18 months to provide them with the best possible solution to satisfy their requirements. Gen-Probe is a world class business and its decision to substantially expand its European operations and establish a new office here in Wythenshawe is a real vote of confidence for the area. Wythenshawe is currently undergoing radical transformation and by attracting international hi-tech companies such as Gen-Probe we are on the right track to realising our ultimate goal of creating a new business destination for the region.”
Sir Richard Leese, leader of Manchester City Council, concluded: “This expansion is excellent news for Wythenshawe. It represents a significant milestone in the regeneration of the area, demonstrating that Wythenshawe can attract and keep top-flight companies. It also further reinforces Manchester’s reputation as an attractive destination for business investment, and in particular scientific and research industries.”
BES will split the construction work into two Phases. Phase 1 will include the redevelopment of the existing laboratories and support offices on the first floor and will be complete early next year. The more substantial Phase 2 includes the construction of the new manufacturing facility on the ground floor and will be complete by the end of 2011.